ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today introduced two innovative solutions at the 2011 European Congress of Radiology (ECR). A mammography solution addresses current limitations of x-ray image diagnosis for the detection of breast cancer, while the interventional radiology solution helps achieve superior, real-time images with the ability for dose reduction during interventional fluoroscopy procedures.
“We are thrilled to launch our newest product innovations, the MAMMO PlusViewCAD and the GOPView iRVUltra, to a prestigious audience of radiology professionals and medical imaging equipment manufacturers”
Routine mammographic screening is an accepted standard for the early detection of breast cancer. However, as many as 1 in 5 cancers are overlooked by the radiologist because the signs on the mammogram may be extremely subtle. With the help of CAD systems, the mammographic image is used to evaluate a patient with abnormal clinical findings and alert the radiologist to the need for further analysis. A study published in the American Journal of Roentgenology found that the use of CAD systems significantly improved the detection of breast cancer by increasing radiologist sensitivity by 21.2%. In conclusion, for every 100,000 women with breast cancer identified without the use of computer-aided detection, an estimated additional 21,200 cancers would be found with the use of computer-aided detection.
MONET: New AI tool enhances medical imaging with deep learning and text analysis